Silanediols: A new class of potent protease inhibitors

Angewandte Chemie - International Edition

Volumn 37, Issue 6, 1998, Pages 812-814

  Sieburth, Scott McN ^a   Nittoli, Thomas ^a   Mutahi, Alfred M ^a   Guo, Luxuan ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

Angiotensin converting enzyme; Enzyme inhibitors; Peptidomimetics; Silanols; Structure activity relationships

Indexed keywords

EID: 0031901524     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-3773(19980403)37:6<812::AID-ANIE812>3.0.CO;2-I     Document Type: Article

References (26)

1. F. O. Stark, J. R. Falender, A. P. Wright in Comprehensive Organometallic Chemistry, Vol. 2 (Eds.: G. Wilkinson, F. G. A. Stone, E. W. Abel), Pergamon, New York, 1982, pp. 305-363; S. S. Brown, T. C. Kendrick, J. McVie, D. R. Thomas in Comprehensive Organometallic Chemistry II, Vol. 2 (Eds.: E. W. Abel, F. G. A. Stone, G. Wilkinson), Pergamon, New York, 1995, pp. 111-135.
2. F. O. Stark, J. R. Falender, A. P. Wright in Comprehensive Organometallic Chemistry, Vol. 2 (Eds.: G. Wilkinson, F. G. A. Stone, E. W. Abel), Pergamon, New York, 1982, pp. 305-363; S. S. Brown, T. C. Kendrick, J. McVie, D. R. Thomas in Comprehensive Organometallic Chemistry II, Vol. 2 (Eds.: E. W. Abel, F. G. A. Stone, G. Wilkinson), Pergamon, New York, 1995, pp. 111-135.
3. P. D. Lickiss, Adv. Inorg. Chem. 1995, 42, 147-262.
4. K. D. Friedberg, E. Schiller, W. B. Farnham in Handbook on Toxicity of Inorganic Compounds (Eds.: H. G. Seiler, H. Sigel), Marcel Dekker, New York, 1988, pp. 595-617.
5. R. Tacke, H. Linon in The Chemistry of Organic Silicon Compounds (Eds.: S. Patai, Z. Rappoport), Wiley, New York, 1989, pp. 1143-1206.
6. S. McN. Sieburth in Designing Safer Chemicals (Eds.: S. C. DeVito, R. L. Garrett), American Chemical Society, Washington, DC, 1996, pp. 74-83.
7. Diphenylsilanediol is the only silanediol that has been found to be biologically active. For an excellent review, see ref. [4].
8. Tacke has reported a series of silanols with outstanding activity as antagonists of the muscarinic receptors: R. Tacke, D. Reichel, M. Kropfgans, P. G. Jones, E. Mutschler, J. Gross, X. Huo, M. Waelbroeck, G. Lambrecht, Organometallics 1995, 14, 251-262, and references therein.
9. R. West, L. S. Wilson, D. L. Powell, J. Organomet. Chem. 1979, 178, 5-9.
10. R. Damrauer, S. R. Kass, C. H. DePuy, Organometallics 1988, 7, 637-640.
11. R. E. Galardy, Z. P. Kortylewicz, Biochem. J. 1985, 226, 447-454.
12. K. Curley, R. F. Pratt, J. Am. Chem. Soc. 1997, 119, 1529-1538.
13. G. Shoham, D. W. Christianson, D. A. Oren, Proc. Natl. Acad. Sci. USA 1988, 55, 684-688.
14. Initial attempts to prepare 7 with a benzyl group rather than an isobutyl group failed.
15. J. P. Tam, R. B. Merrifield in The Peptides. Vol. 9 (Eds.: S. Udenfriend, J. Meienhofer), Academic Press, New York, 1987, pp. 185-248.
16. F. Gharahdaghi, J. Mathers, S. M. Mische in Techniques in Protein Chemistry III (Ed.: R. H. Angeletti), Academic Press, New York, 1992, pp. 199-208.
17. H. J. Emeléus, C. J. Wilkins, J. Chem. Soc. 1944, 454-456; C. Eaborn, J. Chem. Soc. 1952, 2846-2849.
18. H. J. Emeléus, C. J. Wilkins, J. Chem. Soc. 1944, 454-456; C. Eaborn, J. Chem. Soc. 1952, 2846-2849.
19. 1H NMR spectroscopy; 7a and 15a are 1:1 mixtures of diastereomers, and 7b, 14, and 15b are approximately 1:1:1:1 mixtures. Full experimental details will be reported elsewhere.
20. J. R. Henry, S. M. Weinreb, J. Org. Chem. 1993, 58, 4745.
21. W. Uhlig, Chem. Ber. 1996, 129, 733-739.
22. A. R. Bassindale, T. Stout, J. Organomet. Chem. 1984, 271, C1-C3.
23. R. J. P. Corriu, C. Guérin, G. Guirand, J. Chem. Soc. Chem. Commun. 1979, 8-9.
24. D. W. Cushman, H. S. Cheung, Biochem. Pharm. 1971, 20, 1637-1648.
25. B. Holmquist, P. Bünning, J. F. Riordan, Anal. Biochem. 1979, 95, 540-548.
26. R. G. Almquist, J. Crase, C. Jennings-White, R. F. Meyer, M. L. Hoefle, R. D. Smith, A. D. Essenburg, H. R. Kaplan, J. Med. Chem. 1982, 25, 1292-1299.